Idaho Technology (ITI) has received the US Food and Drug Administration (FDA) approval for its nucleic acid amplification In vitro diagnostic (IVD) test that detects Coxiella burnetii, the bacteria that causes Q fever.

The test developed by ITI is used to test military personnel suspected of contracting the disease and run on the Joint Biological Agent Identification and Diagnostics System (JBAIDS), utilized across all branches of the military for diagnostic testing.

Researchers, medical technicians, law enforcement officers, and soldiers in the field use the company’s devices to detect or study disease-causing organisms.

US Department of Health and Human Services and the Department of Defense granted funds through which the company has created many instruments and reagents for use in research and applied fields.

Several of these products, including the LightCycler Instrument, have been sublicensed to Roche Diagnostics.